Optimer Pharmaceuticals, Inc.: Leading Medical Experts Call for More Effective Strategies to Address Clostridium difficile-Associated Disease

SAN DIEGO--(BUSINESS WIRE)--Leading medical experts in the field of Clostridium difficile-Associated Disease or (CDAD), called for more effective strategies to prevent, rapidly diagnose and treat CDAD, according to presentations made during a symposium entitled “Clostridium Difficile-Associated Disease: Underdiagnosed, Underreported, Undertreated; How to Overcome the Challenges” at the Infectious Diseases Society of America (IDSA) Annual Meeting in San Diego, California.